Hideyo Noguchi Africa Prize: Fill & Download for Free

As a “native” Congolese woman, I am not surprised at all by repeated questions on the Ebola outbreaks in eastern DRC.I am also less surprised by the tone and connotation of these repeated questions. As someone put it: You never see the African on TV unless he is starving or he has diseases. Western media tend to focus on Western medical doctors and health workers who risk their lives and assist us in fighting Ebola.I think that it is high time that narratives are changed in order to include exceptional Africans who have dedicated their lives fighting these diseases and who have never really got the credit they deserve. One of them is Congolese doctor and scholar, Professeur Jean-Jacques Muyembe.Ebola now curable after trials of drugs in DRC, say scientists“From now on, we will no longer say that Ebola is incurable,” said Prof Jean-Jacques Muyembe, the director general of the Institut National de Recherche Biomédicale in DRC, which has overseen the trial. “These advances will help save thousands of lives.”Finally, some good news about Ebola: Two new treatments dramatically lower the death rate in a trial“Today, we have started a new chapter. From now on, we will no longer say that Ebola is not curable,” Jean-Jacques Muyembe-Tamfum, head of the DRC’s National Institute for Biomedical Research in Kinshasa, a partner in the trial, said at the press conference. “This advance will, in the future, help save thousands of lives.” (Muyembe, who was part of the team that discovered Ebola 43 years ago, took over command of the outbreak response in the DRC on 22 July.)WARIGI: Inspiring tale of Congolese doctor on the cusp ofJust as remarkable as the latest dramatic advance against Ebola is the identity of a key player behind it all. He is a distinguished Congolese microbiologist, Prof Jean-Jacques Muyembe.The successful new Ebola treatments are the culmination of work Muyembe pioneered during an earlier Ebola outbreak in 1995 in Kikwit, in south-western Congo.Currently the director of Congo’s National Institute for Biomedical Research, he was a lead partner in the clinical trials whose other partners were the US National Institute of Allergy and Infectious Diseases (NIAID) together with the World Health Organisation. Muyembe is acknowledged by his peers as one of the top Ebola researchers in the world. Lancet, a leading medical journal, described him in an article as “the Ebola hunter”Jean-Jacques Muyembe Tamfum: a life’s work on EbolaJean-Jacques Muyembe Tamfum was part of the research team that investigated the first known outbreak of Ebola virus disease in 1976Jean-Jacques Muyembe Tamfum has devoted the last four decades to researching Ebola virus disease. He worked on the World Health Organization (WHO) team that implemented detection and control measures in the first documented urban outbreak of Ebola in Kikwit in 1995 in the Democratic Republic of the Congo. Muyembe is Director-General of the National Institute for Biomedical Research and Professor of Microbiology at Kinshasa University Medical School in the Democratic Republic of the Congo.The Hideyo Noguchi Africa Prize 2019 (Medical Research) - PRESS RELEASE - - Cabinet Office Home PageThe Third Hideyo Noguchi Africa Prize for Medical Research goes to Dr. Jean-Jacques Muyembe-Tamfum for his research to confront Ebola and other deadly viruses and efforts to train legions of disease-fighters.Dr. Jean-Jacques Muyembe-Tamfum has for more than five decades displayed outstanding courage, intelligence and scientific rigor in research and training in the DRC. In particular, in 1976 he identified the existence of a previously unknown disease in his country, collected blood and tissue samples under dangerous conditions, and forwarded them to the Institute of Tropical Medicine in Belgium where the Ebola virus was discovered.Since 1976 Dr. Muyembe-Tamfum has been on the front lines of Ebola research, identifying nosocomial and burial transmission as two of the major causes of disease transmission, contributing to vaccine research, developing antisera therapy and training a new generation of disease responders and Congolese laboratory scientists.Dr. Jean-Jacques Muyembe-Tamfum is an African scientist who was dispatched to Yambuku, a small village in northern area of DRC, where the first outbreak of Ebola virus disease (EVD) occurred in 1976, and he raised an alert about the disease. Since then, he has worked as an expert in tackling and controlling EVD. He was appointed as Chairman of the International and Scientific Committee against EVD outbreaks in Kikwit in 1995 and conducted extensive studies on that outbreak, including reviewing hospital records and interviewing survivors.He found that EVD outbreaks in Kikwit were caused by nosocomial infection. As control measures for EVD, he advocated the isolation of patients in a quarantine ward, the distribution of protective equipment to healthcare workers and family members, the distribution of health educational material, the proper burying of the deceased by a trained team. Undertaken, these actions proved to be effective. In addition, he introduced a sociocultural view to thwart Ebola virus transmission.He recognized traditional burial practice to be one of the major causes of the disease transmission within the community. Thereafter, he explained to local community leaders how the disease is transmitted and provided families with gloves and protective gear. These measures introduced through his leadership proved to be effective when DRC contained the outbreak within 3 months. Applying these experiences, he has been a consultant for WHO, assisting with Ebola and Marburg virus disease outbreaks in other countries.Dr. Muyembe-Tamfum’s scientific contribution is not limited to EVD, but also includes a wide range of diseases.Behind the Life-saving Ebola Vaccine is a Story of Missed OpportunityDr. Jean-Jacques Muyembe, a Congo virologist who was the first to treat a case of Ebola in 1976, is overseeing the country’s response to the virus as well as vaccinations.Ebola veteran promises an end to Congo’s epidemicLater this month, virologist Jean-Jacques Muyembe-Tamfum from the Democratic Republic of the Congo (DRC) will receive a prestigious award from Japanese Emperor Naruhito “for his research to confront Ebola and other deadly viruses and efforts to train legions of disease-fighters.” The recognition, which comes with close to $1 million, is overdue, says David Heymann, an epidemiologist at the London School of Hygiene & Tropical Medicine (LSHTM). In 1976, at age 34, Muyembe was the first virologist ever to see an Ebola patient, and he has helped fight all nine of the outbreaks to strike his country since. Muyembe “has never gotten the credit that he really deserves,” Heymann says

These are allegations made by those who introduced AIDS in Africa in the late 1950s in the then Belgian Congo. I am from the DRC, previously known as the Belgian Congo. We have documented evidence that AIDS was introduced in our country by careless and racist Western doctors.They rather shift the blame and degrade us Africans than accept full responsibility.There are 3 key facts about AIDS that are hardly talked about.HIV and AIDS are on the increase in Eastern Europe ;HIV and AIDS are declining in sub-Saharan Africa ;AIDS is a bio-weapon fabricated by Hilary Koprowski, an American of Polish origin in the Belgian Congo in the 1950sHIV and AIDS in Eastern Europe & Central AsiaEastern Europe and central Asia is the only region in the world where the HIV epidemic continued to rise rapidly, with a 29% increase in annual new HIV infections between 2010 and 2018. The epidemic is concentrated predominantly among key affected populations - in particular, people who inject drugs - yet there is low coverage of harm-reduction and other HIV prevention programmes in key countries within the region.New report says HIV rates keep rising in Eastern EuropeThe European Center for Disease Prevention and the World Health Organization of Europe reports that Eastern Europe continues to experience the highest rates of HIV diagnoses in the world.New HIV infections are falling dramatically in AfricaAfrica has cut AIDS-related deaths by one third in the past six years, the report says. Even countries with the highest HIV prevalence in the world have seen the number of new HIV infections decline dramatically.Malawi has witnessed a 73 per cent drop in new HIV infections. Botswana, Namibia, Zambia and Zimbabwe follow. South Africa managed to reduce new infections by 41 per cent. Even Swaziland — the country with the highest HIV prevalence in the world — saw new HIV infections drop by 37 per cent. Meanwhile, in other regions of Africa, Ghana topped the list, followed by Burkina Faso and Djibouti.HIV/AIDS: trends in the Middle East and North Africa regionWhile the annual number of new HIV infections in Sub-Saharan Africa has declined by 33% since 2005, new HIV infections in the MENA region have increased by 31% since 2001, which is the highest increase among all regions in the world.Aids - our gift to Africa?Now, nine years in the writing, comes The River , a journey to the "source" of Aids. Hooper's massive, 1,000-page piece of medical detective work contends that the HIV epidemic is the work of human hands, in particular the vaccination in the late 1950s of more than a million Africans with an experimental polio virus.It is Hooper's contention that it was a single venture in polio vaccine research which led to the epidemic, the Lindi chimp colony outside Stanleyville (now Kisangani) in the Belgian Congo. It was here, in 1957, that Philadelphia doctor Hilary Koprowski established his research centre, where primate kidneys of some description were treated with the polio virus. By 1959, the chilled vaccine, known for inexplicable reasons as CHAT, had been fed to nearly a million people (most of them children) in the Congo, Uganda, Rwanda and Burundi.'Scientists started Aids epidemic'A polio vaccine using tissue from primates could have been behind the leap made by the human immunodeficiency virus - HIV - from apes and moneys to humans, a new book claims.Dr Hilary Koprowski, a doctor in Philadelphia produced the vaccine in the 1950s when the race was on to prevent a disease that was as feared in its time as cancer or Aids now.Edward Hooper, author of The River, points to a correlation between the sites of mass inoculations using Dr Koprowski's vaccine in the late 1950s and the first recorded cases of Aids in the 1960s.Three parts of the Democratic Republic of Congo - at the time the Belgian Congo and subsequently Zaire - were particularly affected.These were Rouzizi Valley, Lubudi and Leopoldville - where the first case of the disease was detected in a blood sample from 1959.Hilary Koprowski The Aids Spreader And US Navy Dr. Leonard Peruski InterviewWhy did Hilary Koprowski, an American of Polish origin, developed a new method to eradicate the polio problem quickly?The vaccine was indeed easy within monkey kidney cells to produce, but the extract from polio-infected monkey kidney tissue thus obtained, was so badly filtered that only bacteria to the substance have been withdrawn, while in monkey tissue resident deadly viruses, amongst them SV40, freely were passed. Anyone with the contaminated vaccine from Koprowski was handled, thus willingly received viruses that do not occur naturally in humans.After Koprowski vaccines are cheap in the United States had been tested on twenty mentally handicapped children from a mental health facility in New York, he decided the massive preparation to serve in Africa and not first in the United States for which he never gets any permission.To implement its first major immunization, he settled in the Belgian Congo. He built a laboratory building at Camp Lindi in Stanleyville, now called Kisangani, and took out the final tests by all black animal keepers with Chat an l-type vaccine to vaccinate.Apparently, the results to him were satisfactory and as quickly as possible in the northeast of the present Federal Republic of the Congo, Uganda, Rwanda, and Burundi, in the current mass of people in the fifties, he rounded up and directed them massively to vaccination stations.There they were, mostly by Belgian doctors and nurses, the polio-active vaccine with long needles into the open mouths sprayed. The exact number of doses is not known. But estimates indicate that approximately one-quarter of a million men women and children with the strongly contaminated vaccine Type l-Chat is inoculated.About the real impact of the Congo vaccine in this former Belgian colony, thanks to a relentless stream of violent conflicts till today, to date nothing officially announced. From the late fifties, the black population of the Federal Republic of the Congo affected by many diseases whose cause seems difficult to trace.What people have by now discovered that in the case of the polio vaccinations two different methods were used. Hundreds of thousands of Africans were “sprayed” while a contrast to the white “caps” was awarded.The latter method has the advantage that when the vaccine is not viral and bacterial infections in the mouth and the esophagus can occur because the capsule is only dissolved in the stomach. Moreover, a vaccine in a capsule keeps better. In any case, the pause for thought that the application of the spray vaccine in Belgium itself, and whites living in the colony was banned.That the vaccine of Koprowski causes very dangerous side effects is shown in 1959, because of a publication on May 14th of that year when Sabin published an article in the British Medical Journal explaining that he has found an unknown cell-killing virus in the polio vaccine of Koprowski.The thus attacked American scientist, who had vaccinated only black-skinned people massively in the former Belgian Congo, did not respond to this serious accusation. He was nevertheless accepted by a committee of American Congress called to account, which he took off a statement that he developed a chat-type a vaccine which was indeed very much contaminated with numerous serious monkey viruses.Despite the fact that now hundreds of thousands of people are dangerous vaccine-treated, that confession would only mean that Koprowski quietly disappeared from the scientific stage. But his work is dated and can be accounted for and the dying Africans now know that aids causing viruses does not jump to them by accident but deliberately. Some persons even think one can speak of genocide which should be brought to the International Court of Law in the Haque the Netherlands.….I think that it is high time the narratives of Ebola in Africa are changed in order to include exceptional Africans who have dedicated their lives fighting these diseases and who have never really got the credit they deserve. One of them is Congolese doctor and scholar, Professeur Jean-Jacques Muyembe.Ebola now curable after trials of drugs in DRC, say scientists“From now on, we will no longer say that Ebola is incurable,” said Prof Jean-Jacques Muyembe, the director general of the Institut National de Recherche Biomédicale in DRC, which has overseen the trial. “These advances will help save thousands of lives.”Finally, some good news about Ebola: Two new treatments dramatically lower the death rate in a trial“Today, we have started a new chapter. From now on, we will no longer say that Ebola is not curable,” Jean-Jacques Muyembe-Tamfum, head of the DRC’s National Institute for Biomedical Research in Kinshasa, a partner in the trial, said at the press conference. “This advance will, in the future, help save thousands of lives.” (Muyembe, who was part of the team that discovered Ebola 43 years ago, took over command of the outbreak response in the DRC on 22 July.)WARIGI: Inspiring tale of Congolese doctor on the cusp ofJust as remarkable as the latest dramatic advance against Ebola is the identity of a key player behind it all. He is a distinguished Congolese microbiologist, Prof Jean-Jacques Muyembe.The successful new Ebola treatments are the culmination of work Muyembe pioneered during an earlier Ebola outbreak in 1995 in Kikwit, in south-western Congo.Currently the director of Congo’s National Institute for Biomedical Research, he was a lead partner in the clinical trials whose other partners were the US National Institute of Allergy and Infectious Diseases (NIAID) together with the World Health Organisation. Muyembe is acknowledged by his peers as one of the top Ebola researchers in the world. Lancet, a leading medical journal, described him in an article as “the Ebola hunter”Jean-Jacques Muyembe Tamfum: a life’s work on EbolaJean-Jacques Muyembe Tamfum was part of the research team that investigated the first known outbreak of Ebola virus disease in 1976Jean-Jacques Muyembe Tamfum has devoted the last four decades to researching Ebola virus disease. He worked on the World Health Organization (WHO) team that implemented detection and control measures in the first documented urban outbreak of Ebola in Kikwit in 1995 in the Democratic Republic of the Congo. Muyembe is Director-General of the National Institute for Biomedical Research and Professor of Microbiology at Kinshasa University Medical School in the Democratic Republic of the Congo.The Hideyo Noguchi Africa Prize 2019 (Medical Research) - PRESS RELEASE - - Cabinet Office Home PageThe Third Hideyo Noguchi Africa Prize for Medical Research goes to Dr. Jean-Jacques Muyembe-Tamfum for his research to confront Ebola and other deadly viruses and efforts to train legions of disease-fighters.Dr. Jean-Jacques Muyembe-Tamfum has for more than five decades displayed outstanding courage, intelligence and scientific rigor in research and training in the DRC. In particular, in 1976 he identified the existence of a previously unknown disease in his country, collected blood and tissue samples under dangerous conditions, and forwarded them to the Institute of Tropical Medicine in Belgium where the Ebola virus was discovered.Since 1976 Dr. Muyembe-Tamfum has been on the front lines of Ebola research, identifying nosocomial and burial transmission as two of the major causes of disease transmission, contributing to vaccine research, developing antisera therapy and training a new generation of disease responders and Congolese laboratory scientists.Dr. Jean-Jacques Muyembe-Tamfum is an African scientist who was dispatched to Yambuku, a small village in northern area of DRC, where the first outbreak of Ebola virus disease (EVD) occurred in 1976, and he raised an alert about the disease. Since then, he has worked as an expert in tackling and controlling EVD. He was appointed as Chairman of the International and Scientific Committee against EVD outbreaks in Kikwit in 1995 and conducted extensive studies on that outbreak, including reviewing hospital records and interviewing survivors.He found that EVD outbreaks in Kikwit were caused by nosocomial infection. As control measures for EVD, he advocated the isolation of patients in a quarantine ward, the distribution of protective equipment to healthcare workers and family members, the distribution of health educational material, the proper burying of the deceased by a trained team. Undertaken, these actions proved to be effective. In addition, he introduced a sociocultural view to thwart Ebola virus transmission.He recognized traditional burial practice to be one of the major causes of the disease transmission within the community. Thereafter, he explained to local community leaders how the disease is transmitted and provided families with gloves and protective gear. These measures introduced through his leadership proved to be effective when DRC contained the outbreak within 3 months. Applying these experiences, he has been a consultant for WHO, assisting with Ebola and Marburg virus disease outbreaks in other countries.Dr. Muyembe-Tamfum’s scientific contribution is not limited to EVD, but also includes a wide range of diseases.Behind the Life-saving Ebola Vaccine is a Story of Missed OpportunityDr. Jean-Jacques Muyembe, a Congo virologist who was the first to treat a case of Ebola in 1976, is overseeing the country’s response to the virus as well as vaccinations.Ebola veteran promises an end to Congo’s epidemicLater this month, virologist Jean-Jacques Muyembe-Tamfum from the Democratic Republic of the Congo (DRC) will receive a prestigious award from Japanese Emperor Naruhito “for his research to confront Ebola and other deadly viruses and efforts to train legions of disease-fighters.” The recognition, which comes with close to $1 million, is overdue, says David Heymann, an epidemiologist at the London School of Hygiene & Tropical Medicine (LSHTM). In 1976, at age 34, Muyembe was the first virologist ever to see an Ebola patient, and he has helped fight all nine of the outbreaks to strike his country since. Muyembe “has never gotten the credit that he really deserves,” Heymann says

In the Congo rainforest, the doctor who discovered Ebola warns of deadly viruses yet to come. What was the actual incident?The doctor you refer to is Professor Jean-Jacques Muyembe Tamfum. His team discover the Ebola virus in 1976; he has been on the frontline of the hunt for new pathogens ever since. During a television program to be shown on CNN International Thursday, December 24 at 3:30 p.m. ET, Friday, December 25 at 2:30 a.m. ET, and Sunday, December 27 at 9:30 a.m. ET, Muyembe will discuss his belief that many more zoonotic diseases -- those that jump from animals to humans -- will come out and constitute a threat to humanity. In the Congo rainforest, the doctor who discovered Ebola warns of deadly viruses yet to come“He believes future pandemics could be more apocalyptic than COVID-19.” Doctor who discovered Ebola warns more viruses will pose ‘threat to humanity’ after COVID-19. SARS-CoV-2 is highly transmissible—two new strains have been discovered in the UK and in South Africa. He predicts that one or more of the emerging viruses could be as deadly as Ebola, which kills 90% of its victims.Professor Jean-Jacques Muyembe-Tamfum holds a test tube tray during an Ebola epidemic. Source: Getty ImagesJean-Jacques Muyembe-Tamfum of Congo (Left) poses with Japan's Prime Minister Shinzo Abe after receiving the Third Hideyo Noguchi Africa Prize in the medical research category during the awards ceremony in Tokyo on August 30, 2019. Source: Getty ImagesAs part of the effort of looking to the future, he and other “researchers are now watching for ‘Disease X’ – a pathogen that could sweep the world as fast as SARS-CoV-2 but with Ebola’s shocking fatality rate.”Ebola discovery—Zoonotic virusesMuyembe has had first-hand experience with a new virus while he was working at the Yambuku Mission Hospital where the disease that causes hemorrhages and killed about 88% of patients and 80% of the staff when it was first discovered in 1976. Doctor who discovered Ebola warns more viruses will pose ‘threat to humanity’ after COVID-19Yellow fever, caused by a zoonotic virus and the first animal-to-human infection was identified in 1901. Since then, more than 200 viruses that can infect humans and cause disease. Three to four new species of such viruses are being discovered each year. Most come from animals. In the Congo rainforest, the doctor who discovered Ebola warns of deadly viruses yet to come“Prof Muyembe now runs the Institut National de Recherche Biomédicale in Kinshasa, capital of the Democratic Republic of Congo. He and other experts believe that the rising number of emerging viruses is largely the result of ecological destruction and wildlife trade.”As their natural habitats disappear, animals like rats, bats, and insects survive where larger animals get wiped out. They're able to live alongside human beings and are frequently suspected of being the vectors that can carry new diseases to humans.““We cut the trees; we kill the animals or cage them and send them to markets. We disrupt ecosystems, and we shake viruses loose from their natural hosts. When that happens, they need a new host. Often, we are it.”Viruses and their hostsEbola infects humans and primates. This virus, as well as the Marburg virus which also causes hemorrhaging, are part of the Filoviridae family.SARS (Severe Acute Respiratory Syndrome) and MERS (Middle East Respiratory Syndrome ) are of the coronavirus family. The initial SARS is now called SARS-CoV-1 or SARS-1.To date, scientists have identified five strains of Ebola - four of which are known to cause disease in humans. The graph below compares infections and deaths of Ebola and SARS. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2There is certainly precedence for zoonotic viruses that use other animals as hosts and have “jumped” from these animals to humans. That is the basis for Muyembe’s warning that more viruses will pose ‘threat to humanity’Other sources: Yahoo Search - Web Search Discoverer of Ebola virusDoctor who discovered Ebola warns MORE killer viruses are coming after CovidFiloviridae vs coronavirus Yahoo Search - Web SearchSee How Ebola's Spread Compares to Other Deadly Outbreaks